Search by keywords: Upcoming Seminars and Events View upcoming seminars and events. Learn more 550 News Items found Honors Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Melanoma “Dream Team” Wednesday, December 14, 2011 Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma. In the Lab Findings Could Lead to the Development of a New Painkiller Tuesday, December 13, 2011 Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers. In the Lab Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy Friday, December 2, 2011 Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor. Profile Genetic Causes of Blood Cancers Explored Thursday, December 1, 2011 German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma. Out of the Lab and into the World: Hsp90 Inhibitor, a New Cancer Drug Thursday, December 1, 2011 A dynamic mix of experts in biology, chemistry, and medicine come together in the Sloan Kettering Institute lab of chemical biologist Gabriella Chiosis to investigate chaperone proteins involved in cancer. Feature Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients Thursday, December 1, 2011 Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments. Out of the Lab and into the World: The Endoscopic Laser Scalpel Thursday, December 1, 2011 A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe. Perspective President Craig Thompson Reflects on 40-Year War on Cancer Thursday, December 1, 2011 Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain. Research Suggests Potential Immune Therapy for Preventing Breast Cancer Metastasis Thursday, December 1, 2011 A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells. Biologist Scott Lowe Joins Memorial Sloan Kettering Saturday, October 1, 2011 Scott W. Lowe has joined Memorial Sloan Kettering Cancer Center as a member of the Cancer Biology and Genetics Program in the Sloan Kettering Institute and Chair of the Geoffrey Beene Cancer Research Center. Pagination Load More